This is a reminder that the EUCAST public consultation on carbapenem susceptibility testing and reporting ends on the 30 September, 2025: The proposed addition of a comment for carbapenemase-producing Enterobacterales. See also additional information in the Appendix. To respond to the consultation,…
Get to know morePublic consultation Public consultation is part of the EUCAST decision process. The consultation period is 4 - 12 weeks, and the dates of the beginning and end of the period is clearly stated. Previous public consultations with comments and EUCAST responses 2025 Archive Proposed new breakpoints for…
Get to know morePublic Consultations Public consultation is part of the EUCAST decision process. The consultation period is 4 - 12 weeks, and the dates of the beginning and end of the period is clearly stated. Previous public consultations with comments and EUCAST responses 2025 2024 2023 Archive The (preliminary)…
Get to know moreProposed revision of breakpoints for trimethoprim-sulfamethoxazole and trimethoprim. Public consultation 2025-05-07 - 2025-06-18. As a final result of each consultation, the comments obtained and the EUCAST Steering Committee rersponses are made public on the website. These are public comments and…
Get to know morePublic Consultations Public consultation is part of the EUCAST decision process. The consultation period is 4 - 12 weeks, and the dates of the beginning and end of the period is clearly stated. Current public consultations Subject Dates Description Carbapenem susceptibility testing and reporting -…
Get to know moreSitemap EUCAST - Home About EUCAST Organisation Steering Committee General Committee EUCAST Statutes National AST Committees (NAC) Network Laboratories Development Laboratories (EDL) Subcommittees Antimycobacterial Susceptibility Testing (AMST) Antifungal Susceptibility Testing (AFST) Veterinary…
Get to know moreEUCAST public consultation on breakpoints for intravenous use of fosfomycin . Consultation period 12 July - 12 September, 2023. The proposal has been revised following comments to the previous consultation and discussions with the EUCAST Steering Committee and stakeholders. Do not iterate comments…
Get to know moreFollowing public consultation, EUCAST publishes formal responses to queries and views submitted during the consultation period. The comments during the consultation on EUCAST proposed endocarditis breakpoints , the EUCAST responses and decisions are now published (20 November, 2024). Throughout the…
Get to know moreProposed change of breakpoints for aminopenicillins in enterococci (consultation period 7 May - 14 June, 2024). Public consultation is part of the EUCAST decision process. The consultation period is 4 - 12 weeks, and the dates of the beginning and end of the period is clearly stated. Comments not…
Get to know moreDevelopment of Clinical Breakpoints and ECOFFs These pages collate information on the definition of clinical breakpoints and the process of setting MIC breakpoints. Background information is given in the Rationale Documents and in Public Consultations and the MIC:ZD (MIC vs. zone diameter)…
Get to know more
We’ve prepared a short video to help you get familiar with the new layout and features.